about
Neuroendocrine immunoregulation in multiple sclerosisAryl hydrocarbon receptor control of adaptive immunityFingolimod: direct CNS effects of sphingosine 1-phosphate (S1P) receptor modulation and implications in multiple sclerosis therapyTwo-photon microscopy imaging of thy1GFP-M transgenic mice: a novel animal model to investigate brain dendritic cell subsets in vivoNative cellulose nanofibrills induce immune tolerance in vitro by acting on dendritic cellsGYF-21, an Epoxide 2-(2-Phenethyl)-Chromone Derivative, Suppresses Innate and Adaptive Immunity via Inhibiting STAT1/3 and NF-κB Signaling PathwaysDeficiency of the G protein Gαq ameliorates experimental autoimmune encephalomyelitis with impaired DC-derived IL-6 production and Th17 differentiationSuppression of Th1-mediated autoimmunity by embryonic stem cell-derived dendritic cellsExacerbation of experimental autoimmune encephalomyelitis in mice deficient for DCIR, an inhibitory C-type lectin receptor.Discovery of BVDU as a promising Drug for autoimmune diseases Therapy by Dendritic-cell-based functional screeningH(1)R expression by CD11B(+) cells is not required for susceptibility to experimental allergic encephalomyelitisBlocking A2B adenosine receptor alleviates pathogenesis of experimental autoimmune encephalomyelitis via inhibition of IL-6 production and Th17 differentiation.Natural killer cells and their receptors in multiple sclerosis.Regulation of central nervous system autoimmunity by the aryl hydrocarbon receptor.Tolerogenic Dendritic Cells Generated with Tofacitinib Ameliorate Experimental Autoimmune Encephalomyelitis through Modulation of Th17/Treg Balance.IL-27 acts on DCs to suppress the T cell response and autoimmunity by inducing expression of the immunoregulatory molecule CD39.Modulation of dendritic cell function by PGE2 and DHA: a framework for understanding the role of dendritic cells in neuroinflammation.Targeting BCL2 family in human myeloid dendritic cells: a challenge to cure diseases with chronic inflammations associated with bone loss.MicroRNA223 promotes pathogenic T-cell development and autoimmune inflammation in central nervous system in mice.Selective depletion of CD11c+ CD11b+ dendritic cells partially abrogates tolerogenic effects of intravenous MOG in murine EAE.Accumulation and therapeutic modulation of 6-sulfo LacNAc(+) dendritic cells in multiple sclerosisFingolimod additionally acts as immunomodulator focused on the innate immune system beyond its prominent effects on lymphocyte recirculationDiffering Outcome of Experimental Autoimmune Encephalitis in Macrophage/Neutrophil- and T Cell-Specific gp130-Deficient Mice.
P2860
Q26864449-7470DFCC-E90E-4DFA-AEE3-B34E9E926D51Q26991793-F16242CC-7623-45A5-BA5B-D0201F543E0DQ27011473-701AA7E5-EE01-490F-A978-016B01C2A079Q27315015-2E625850-130C-40D8-8B4E-B01150E141ABQ27317032-CC9D1501-B5E4-46A1-8619-8A6BD343248BQ33710758-E1E7A609-8124-423D-930B-5AEE055CB7A5Q33920152-4AC34B20-5D5B-4A37-82DB-8D5AB10C0F5BQ34734082-808C8013-CC4E-426B-BD4F-7EB0B1295059Q35594364-77B26E7A-118B-4874-AD83-DE8CB3670E84Q36300489-69E87C9B-AC59-410C-90F1-B6A91D89460CQ36374681-440CB1B4-9503-495D-9A8A-B3B145704245Q36516815-B9FD0669-B57F-4D8A-BAD2-1C8C9837DBE0Q37124504-08C9C214-CD02-4A69-9B7B-81778C073AFCQ37284511-96A75B35-A531-47EE-8CBD-1B3AD87150FBQ37533397-22669339-3CBB-45F0-94E9-083072F723CEQ37659617-C46B47B1-18AA-4312-9305-2D470E096FA7Q37909028-6E371337-386A-4E09-8C49-1226CDD6E085Q38114069-AFD4FDFE-7646-4B99-9672-E4B1E82AEDC9Q39847582-1706BBE4-4448-4863-AC1F-C42BB6784925Q41641061-5AC1C5F4-7C6E-4F94-8CF3-59415178F933Q41887568-14DA376E-551E-4951-B37B-B91140A911F3Q42320254-37C3DBE1-C1B0-4356-BD26-CE23EF5F311AQ54209318-2FE830F6-D515-45CE-ACC9-1D534F8A5492
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 August 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Targeting dendritic cells to treat multiple sclerosis.
@en
Targeting dendritic cells to treat multiple sclerosis.
@nl
type
label
Targeting dendritic cells to treat multiple sclerosis.
@en
Targeting dendritic cells to treat multiple sclerosis.
@nl
prefLabel
Targeting dendritic cells to treat multiple sclerosis.
@en
Targeting dendritic cells to treat multiple sclerosis.
@nl
P2860
P1476
Targeting dendritic cells to treat multiple sclerosis
@en
P2093
Christian Münz
Manuel Comabella
P2860
P2888
P304
P356
10.1038/NRNEUROL.2010.112
P407
P577
2010-08-17T00:00:00Z